tiprankstipranks
Trending News
More News >
Cipher Pharmaceuticals (TSE:CPH)
TSX:CPH
Canadian Market

Cipher Pharmaceuticals (CPH) Financial Statements

Compare
84 Followers

Cipher Pharmaceuticals Financial Overview

Cipher Pharmaceuticals's market cap is currently $324.39M. The company's EPS TTM is C$0.139067552; its P/E ratio is 25.24; Cipher Pharmaceuticals is scheduled to report earnings on May 8, 2025, and the estimated EPS forecast is C$0.22. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 33.36M$ 21.16M$ 20.68M$ 21.94M$ 21.61M
Gross Profit$ 24.10M$ 17.09M$ 16.68M$ 18.26M$ 18.55M
Operating Income$ 7.85M$ 11.53M$ 12.04M$ 11.82M$ 12.20M
EBITDA$ 11.87M$ 11.53M$ 12.04M$ 13.66M$ 13.40M
Net Income$ 11.54M$ 20.38M$ 26.64M$ 7.76M$ 4.55M
Balance Sheet
Cash & Short-Term Investments$ 17.84M$ 39.83M$ 28.84M$ 20.55M$ 9.14M
Total Assets$ 162.51M$ 86.03M$ 73.78M$ 51.65M$ 44.28M
Total Debt$ 40.58M$ 353.00K$ 428.00K$ 516.00K$ 1.85M
Net Debt$ 22.74M$ -39.47M$ -28.41M$ -20.03M$ -7.29M
Total Liabilities$ 60.17M$ 5.51M$ 9.70M$ 12.75M$ 11.63M
Stockholders' Equity$ 102.34M$ 80.52M$ 64.08M$ 38.90M$ 32.64M
Cash Flow
Free Cash Flow$ 19.50M$ 15.98M$ 10.49M$ 13.81M$ 10.93M
Operating Cash Flow$ 19.55M$ 16.00M$ 10.57M$ 13.81M$ 11.69M
Investing Cash Flow$ -80.04M$ -144.00K$ -81.00K$ 0.00$ -760.00K
Financing Cash Flow$ 39.30M$ -5.24M$ -1.91M$ -2.47M$ -8.13M
Currency in USD

Cipher Pharmaceuticals Earnings and Revenue History

Cipher Pharmaceuticals Debt to Assets

Cipher Pharmaceuticals Cash Flow

Cipher Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis